Vascular endothelial lesion in patients undergoing bone marrow transplantation.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 8932851)

Published in Bone Marrow Transplant on November 01, 1996

Authors

S Richard1, M Seigneur, A Blann, R Adams, M Renard, M Puntous, J M Boiron, J Amiral, J Reiffers, M Boisseau

Author Affiliations

1: Laboratoire d'Hématologie, Université de Bordeaux II, France.

Articles by these authors

Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med (2001) 5.31

For debate . . . medical research output 1973-81: a romp around the United Kingdom research centres. Br Med J (Clin Res Ed) (1984) 3.32

The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology (2007) 3.24

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance. Blood (2000) 3.01

Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood (1999) 2.79

On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology (1985) 2.77

Rescue of arrested replication forks by homologous recombination. Proc Natl Acad Sci U S A (2001) 2.68

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65

In vivo model of adeno-associated virus vector persistence and rescue. J Virol (1996) 2.41

Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome. Br J Haematol (2003) 2.36

Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost (1992) 2.31

Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J Virol (1992) 2.30

Drosophila polo kinase is required for cytokinesis. J Cell Biol (1998) 2.30

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia (2005) 2.24

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. J Infect Dis (1995) 2.20

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1997) 2.18

Procoagulant and proinflammatory activity in acute coronary syndromes. Cardiovasc Res (1998) 2.12

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse. Blood (1992) 2.11

Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood (1994) 2.10

What factors are associated with physical activity in older people, assessed objectively by accelerometry? Br J Sports Med (2008) 2.07

Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells. Exp Hematol (1995) 1.99

What's new in blood progenitor cell autotransplants? Bone Marrow Transplant (1994) 1.98

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia (2003) 1.96

Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost (1994) 1.96

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group. N Engl J Med (1995) 1.94

von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res (1997) 1.83

Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology (Oxford) (2001) 1.82

Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol (1995) 1.76

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. J Clin Oncol (2000) 1.73

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood (1991) 1.73

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders. Blood (2001) 1.67

The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol (1996) 1.64

Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma. Br J Surg (2009) 1.52

Whole-body cooling of hyperthermic runners: comparison of two field therapies. Am J Emerg Med (1996) 1.51

Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells. Leuk Res (1997) 1.50

Outbreak of tuberculosis in a migrants' shelter, Paris, France, 2002. Int J Tuberc Lung Dis (2005) 1.50

Overland flow delivery of faecal bacteria to a headwater pastoral stream. J Appl Microbiol (2005) 1.49

Mechanisms underlying the early establishment of thalamocortical connections in the rat. J Neurosci (1998) 1.49

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48

New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. Haematologica (1997) 1.47

Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther (1996) 1.45

Antisense oligomers in chronic myeloid leukaemia. Lancet (1993) 1.45

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant (2000) 1.44

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur Cytokine Netw (1991) 1.42

Management of the asymptomatic primary in the palliative treatment of metastatic colorectal cancer. Colorectal Dis (2008) 1.42

Fertility experience of juvenile girls: a community-wide ten-year study. Am J Public Health Nations Health (1969) 1.41

Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines. J Lab Clin Med (1996) 1.39

Methods for calculating the deadtime of Anger camera systems. J Nucl Med (1973) 1.39

Caution: disability cover 'trap'. Aust Vet J (2001) 1.39

uvrD mutations enhance tandem repeat deletion in the Escherichia coli chromosome via SOS induction of the RecF recombination pathway. Mol Microbiol (1997) 1.39

Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38

A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J Interferon Cytokine Res (1999) 1.38

Allogeneic bone marrow transplantation versus chemotherapy in first-remission acute myeloid leukemia. J Clin Oncol (1989) 1.36

Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia (1997) 1.36

A randomized controlled trial of a passive accessory joint mobilization on acute ankle inversion sprains. Phys Ther (2001) 1.36

Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol (2001) 1.36

Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM). Br J Haematol (1997) 1.33

Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. Br J Cancer (2011) 1.33

Bacteriology of spoilage of fish muscle. IV. Role of protein. Appl Microbiol (1967) 1.31

Allogeneic bone marrow transplantation for low-grade lymphoma. Blood (1998) 1.29

Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry (1991) 1.29

Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation (1997) 1.28

A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry (1994) 1.28

Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis (1996) 1.28

Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract (2001) 1.28

Genetic control of oil content in oilseed rape (Brassica napus L.). Theor Appl Genet (2006) 1.26

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle. Blood (1996) 1.23

Spontaneous hybridization between a male-sterile oilseed rape and two weeds. Theor Appl Genet (1994) 1.22

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. Hematol Oncol Clin North Am (2000) 1.22

Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Blood (1997) 1.20

Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med (1999) 1.19

Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide. J Clin Microbiol (1990) 1.19

Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa. J Clin Oncol (2002) 1.18

Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia. Circulation (1999) 1.17

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer (2010) 1.16

A public health framework for addressing black and white disparities in preterm delivery. J Am Med Womens Assoc (2001) 1.16

Grip strength testing reliability. J Hand Ther (1994) 1.15

A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis (1991) 1.14

The impact of physicians' brief smoking cessation counseling: a MIRNET study. J Fam Pract (1990) 1.13

Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J Intern Med (2005) 1.13

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM). Br J Haematol (2000) 1.13

Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. J Am Coll Cardiol (1993) 1.13

Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br J Haematol (2000) 1.12

In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients. Antimicrob Agents Chemother (1990) 1.11

Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol (2000) 1.11

Stroke rehabilitation: are highly structured units more conducive to physical activity than less structured units? Arch Phys Med Rehabil (1996) 1.11

Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle. J Clin Oncol (1997) 1.11

Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. Arthritis Rheum (1999) 1.10

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia (1997) 1.10

Clinical tests for ankle syndesmosis injury: reliability and prediction of return to function. J Orthop Sports Phys Ther (1998) 1.09

The role of the first postmitotic cortical cells in the development of thalamocortical innervation in the reeler mouse. J Neurosci (1998) 1.08

A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis. Clin Cancer Res (2000) 1.08

Expression of neurotrophins and their receptors in human bone marrow. Am J Pathol (1999) 1.08

Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus co-infection. Int J Tuberc Lung Dis (2005) 1.07

Infantile fibrosarcoma. Med Pediatr Oncol (1991) 1.07

ENDOBRONCHIAL PROBING COMBINED WITH SERIAL SELECTIVE BRONCHOGRAPHY FLUOROSCOPICALLY CONTROLLED. Ann Surg (1937) 1.07

Quantum efficiency of light-driven proton extrusion in Halobacterium halobium. pH dependence. Biophys J (1980) 1.06